New model focuses on continuity of care, combining therapy, routine and social engagement to support long-term recovery
Founded by Amit Patni, the company rolls out 90+ formulations across acute and specialty therapies
VESCOP, ENTOD Pharmaceuticals, and APTI-MSB host the event to bridge lab-to-clinic gap in eye care
The investigational therapy, MDX2003, is designed to go after cancer cells with a multi-pronged immune attack
Sanplatec is leading the industry in the field of containers and devices for cell culture and live transport
Approval for Albuterol Sulfate inhalation aerosol enables Cipla Limited to enter the $1.5 billion U.S. albuterol market
Stakeholders call for coordinated action on diagnostics, vaccines, and health system readiness as the monsoon season approaches
The study is being conducted through its Japan-based pharmaceutical arm, Asahi Kasei Therapeutics Corp
While many cases are treatable, a subset can become highly aggressive, spreading to distant organs and resisting conventional therapies
The newly approved pill combines 100 mg of doravirine with 0.25 mg of islatravir
Subscribe To Our Newsletter & Stay Updated
